Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The immunoproteasome (IP) is usually viewed as favoring the production of antigenic peptides presented by MHC class I molecules, mainly because of its higher cleavage activity after hydrophobic residues, referred to as the chymotrypsin-like activity. However, some peptides have been found to be better produced by the standard proteasome. The mechanism of this differential processing has not been described. By studying the processing of three tumor antigenic peptides of clinical interest, we demonstrate that their differential processing mainly results from differences in the efficiency of internal cleavages by the two proteasome types. Peptide gp100(209-217) (ITDQVPSFV) and peptide tyrosinase369-377 (YMDGTMSQV) are destroyed by the IP, which cleaves after an internal hydrophobic residue. Conversely, peptide MAGE-C2(336-344) (ALKDVEERV) is destroyed by the standard proteasome by internal cleavage after an acidic residue, in line with its higher postacidic activity. These results indicate that the IP may destroy some antigenic peptides due to its higher chymotrypsin-like activity, rather than favor their production. They also suggest that the sets of peptides produced by the two proteasome types differ more than expected. Considering that mature dendritic cells mainly contain IPs, our results have implications for the design of immunotherapy strategies.

Original publication

DOI

10.4049/jimmunol.176.2.1053

Type

Journal article

Journal

J Immunol

Publication Date

15/01/2006

Volume

176

Pages

1053 - 1061

Keywords

Amino Acid Sequence, Antigen Presentation, Antigens, Antigens, Neoplasm, Binding Sites, Cell Line, Dendritic Cells, Humans, Membrane Glycoproteins, Molecular Sequence Data, Monophenol Monooxygenase, Neoplasm Proteins, Oligopeptides, Peptide Fragments, Proteasome Endopeptidase Complex, gp100 Melanoma Antigen